Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.
Two siblings with m ild hemorrhagic symptoms had combined functional deficiencies of vitamin K-dependent clotting factors. Prothrombin (0.18-0.20 U/ml) and Stuart factor (Factor X, 0.18-0.20 U/ml) and Stuart factor (Factor X, 0.18-0.20 U/ml) were most severely affected. Antigenic amounts of affected coagulation factors were normal and normal generation of thrombin activity occurred in the patients' plasmas after treatment with nonophysiologic activators that do not require calcium for prothrombin activation. Hepatobilary disease, malabsorptive disorders, and plasma warfarin were not present. Both parents had normal levels of all coagulation factors. The patients' plasmas contained prothrombin that reacted both with antibody directed against des-gamma-carboxyprothrombin and native prothrombin. Crossed immunoelectrophoresis of patients' plasmas and studies of partially purified patient prothrombin suggested the presence of a relatively homogeneous species of dysfunctional prothrombin, distinct from the heterologous species found in the plasma of warfarin-treated persons. These studies are most consistent with a posttranslational defect in hepatic carboxylation of vitamin K-dependent factors. This kindred uniquely possesses an autosomal recessive disorder of vitamin K-dependent factor formation that causes production of an apparently homogeneous species of dysfunctional prothrombin; the functional deficiencies in clotting factors are totally corrected by oral or parenteral administration of vitamin K1.
D000293:Adolescent; D000328:Adult; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism; D005171:Factor X Deficiency / Q000097:blood / Q000150:complications* / Q000235:genetics; D005260:Female; D002836:Hemophilia B / Q000150:complications; D006801:Humans; D007020:Hypoprothrombinemias / Q000150:complications*; D007123:Immunoelectrophoresis, Two-Dimensional; D008297:Male; D010314:Partial Thromboplastin Time; D011516:Prothrombin / Q000032:analysis / Q000276:immunology; D011517:Prothrombin Time; D014813:Vitamin K Deficiency / Q000097:blood / Q000150:complications* / Q000235:genetics; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D011516:Prothrombin; D002118:Calcium